XML 183 R167.htm IDEA: XBRL DOCUMENT v3.20.4
Income Tax - Schedule of Income Tax Benefit (Details) (Brooklyn ImmunoTherapeutics, LLC) (10-K) - USD ($)
2 Months Ended 3 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Nov. 05, 2018
Dec. 31, 2019
Dec. 31, 2018
Federal: Current             $ 21,000
Federal: Deferred            
State and local: Current             (25,000) (21,000)
State and local: Deferred             2,000 6,000
Change in valuation allowance             (429,000) (20,000)
Income tax benefit (provision)   $ (19,000) $ 19,000 $ (23,000) $ 30,000   27,000 $ (64,000)
Brooklyn Immunotherapeutics, LLC [Member] | Successor [Member]                
Federal: Current            
Federal: Deferred            
State and local: Current            
State and local: Deferred 80,179           357,482  
Federal, State and local: Current and Deferred 80,179           357,482  
Change in valuation allowance (80,179)           (357,482)  
Income tax benefit (provision)            
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member]                
Federal: Current              
Federal: Deferred           8,266,417    
State and local: Current              
State and local: Deferred           5,438,948    
Federal, State and local: Current and Deferred           13,705,365    
Change in valuation allowance           (13,705,365)    
Income tax benefit (provision)